Loading clinical trials...
Loading clinical trials...
The purpose of this proof-of-concept study is to determine whether gevokizumab is effective in the treatment of active inflammatory, erosive osteoarthritis of the hand.
Keep your clinical trial research organized — questions to ask, what to expect, and key details.
Lead Sponsor
XOMA (US) LLC
NCT06702046 · Osteoarthritis (OA) of the Knee
NCT07551245 · Knee Arthritis Osteoarthritis
NCT06755697 · Knee Osteoarthritis, Glucose, and more
NCT07217405 · Osteoarthritis Hand, Osteoarthritis Wrist
NCT05986292 · Osteoarthritis, Knee, Diabetic Neuropathic Pain, and more
Huntsville, Alabama
Tucson, Arizona
Little Rock, Arkansas
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Start free trial →Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions